Continuing Medical Education: CME 2010: Infectious Disease CME: Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition: CME Outfitters: Web-based CME: Wednesday, June 23, 2010 - June 23, 2011
http://www.cmenetworks.com/cme/11561/1/Continuing-Medical-Education-CME-2010-Infectious-Disease-CME-Pneumococcal-Disease-in-High-Risk-Patients-Prevention-Guidelines-and-Early-Recognition-CME-Outfitters-Web-based-CME-Wednesday-June-23-2010---June-23-2011/Page1.html
CME Outfitters
CME Outfitters is an independent accredited healthcare communications agency providing multidisciplinary continuing medical education content development, production, marketing, accreditation, and project management services to the healthcare industry.
By CME Outfitters
Published on 05/11/2010
Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition
CME Outfitters, LLC
Wednesday, June 23, 2010 - June 23, 2011
CME Sponsor:
CME Outfitters, LLC
Location: Online
Course Directors/Instructors:
Larry Culpepper, MD, MPH
Professor and Chairman
Department of Family Medicine
Boston University School of Medicine
Chief, Division of Family Medicine
Boston Medical Center
Boston, MA
Keith P. Klugman, MD, PhD
William H. Foege Professor of Global Health
Rollins School of Public Health
Professor of Medicine, Division
of Infectious Diseases
Emory University School of Medicine
Atlanta, GA
Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine
University of Minnesota
Associate Chief of Staff for Research
Minneapolis VA Medical Center
Minneapolis, MN
Number of Credits:
1.0 AMA PRA Category 1 Credits™
1.0 Contact Hours
Registration Fee: Free
More Info
Detailed Description:
Pneumococcal disease is a very serious illness in high-risk populations such as children, smokers, the elderly and patients who are immunocompromised. Although the best defense against pneumococcal infection is vaccination, the pneumococcal vaccine remains underutilized in the inpatient setting. Clinicians must be alert to the risk factors for pneumococcal disease, and the high-risk conditions associated with pneumococcal infection for which vaccination is recommended. Guidelines for the prevention and management of pneumococcal disease emphasize the importance of vaccination as well as the need for appropriate and timely antimicrobial therapy. Accurate diagnosis of pneumococcal infection is imperative for early and effective treatment. In this interactive CME Outfitters Live and On Demand activity, faculty will discuss the importance of vaccination for high-risk populations, highlight methods to improve early recognition and diagnosis of pneumococcal disease, and propose practical strategies that can be utilized to advance prevention and treatment for patients at high risk for pneumococcal infection.
Learning Objectives:
At the end of this CE activity, participants should be able to:
• Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
• Implement treatment guidelines and recommendations into clinical practice to advance the prevention and treatment of pneumococcal disease.
• Identify methods to improve the early recognition and diagnosis of pneumococcal disease.
The following learning objectives pertain only to those requesting CNE credit:
• Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
• Describe treatment guidelines and recommendations for the prevention and treatment of pneumococcal disease.
• Identify methods to improve the early recognition and diagnosis of pneumococcal disease.
Intended Audience:
Infectious disease physicians, primary care physicians, pediatricians, geriatricians, hospitalists, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in pneumococcal disease and infection.
Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition
CME Outfitters, LLC
Wednesday, June 23, 2010 - June 23, 2011
Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition
CME Sponsor:
CME Outfitters, LLC
Location: Online
Course Directors/Instructors:
Larry Culpepper, MD, MPH
Professor and Chairman
Department of Family Medicine
Boston University School of Medicine
Chief, Division of Family Medicine
Boston Medical Center
Boston, MA
Keith P. Klugman, MD, PhD
William H. Foege Professor of Global Health
Rollins School of Public Health
Professor of Medicine, Division
of Infectious Diseases
Emory University School of Medicine
Atlanta, GA
Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine
University of Minnesota
Associate Chief of Staff for Research
Minneapolis VA Medical Center
Minneapolis, MN
Number of Credits:
1.0 AMA PRA Category 1 Credits™
1.0 Contact Hours
Registration Fee: Free
More Info
Detailed Description:
Pneumococcal disease is a very serious illness in high-risk populations such as children, smokers, the elderly and patients who are immunocompromised. Although the best defense against pneumococcal infection is vaccination, the pneumococcal vaccine remains underutilized in the inpatient setting. Clinicians must be alert to the risk factors for pneumococcal disease, and the high-risk conditions associated with pneumococcal infection for which vaccination is recommended. Guidelines for the prevention and management of pneumococcal disease emphasize the importance of vaccination as well as the need for appropriate and timely antimicrobial therapy. Accurate diagnosis of pneumococcal infection is imperative for early and effective treatment. In this interactive CME Outfitters Live and On Demand activity, faculty will discuss the importance of vaccination for high-risk populations, highlight methods to improve early recognition and diagnosis of pneumococcal disease, and propose practical strategies that can be utilized to advance prevention and treatment for patients at high risk for pneumococcal infection.
Learning Objectives:
At the end of this CE activity, participants should be able to:
• Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
• Implement treatment guidelines and recommendations into clinical practice to advance the prevention and treatment of pneumococcal disease.
• Identify methods to improve the early recognition and diagnosis of pneumococcal disease.
The following learning objectives pertain only to those requesting CNE credit:
• Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
• Describe treatment guidelines and recommendations for the prevention and treatment of pneumococcal disease.
• Identify methods to improve the early recognition and diagnosis of pneumococcal disease.
Intended Audience:
Infectious disease physicians, primary care physicians, pediatricians, geriatricians, hospitalists, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in pneumococcal disease and infection.